Search Results - "Mertens, W. C"

Gemcitabine in advanced renal cell carcinoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group by Mertens, W C, Eisenhauer, E A, Moore, M, Venner, P, Stewart, D, Muldal, A, Wong, D

“…Gemcitabine (2', 2'-difluorodeoxycytidine; dFdC) an anticancer agent with activity in preclinical models, was felt to be a promising new chemotherapy drug…”
Get more information

Systemic bone-seeking radionuclides for palliation of painful osseous metastases: current concepts by Mertens, W. C, Filipczak, L. A, Ben-Josef, E, Davis, L. P, Porter, A. T

“…Bone metastases require multidisciplinary treatment, the primary goal of which is to relieve pain and improve quality of life. Among the options available,…”
Get full text

Radionuclide therapy of bone metastases: prospects for enhancement of therapeutic efficacy by Mertens, W C

“…Systemically administered, beta-emitting radionuclides provide effective pain relief for many patients with symptomatic osseous metastases. Unfortunately,…”
Get more information

Metastatic melanoma from intraocular primary tumors: The Southwest Oncology Group experience in phase II advanced melanoma clinical trials by FLAHERTY, L. E, UNGER, J. M, LIU, P. Y, MERTENS, W. C, SONDAK, V. K

“…Ocular melanoma is an uncommon malignancy that, in the presence of metastatic disease, has a poor prognosis for response to treatment and survival. Patients…”
Get full text

Docetaxel in advanced renal carcinoma. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group by Mertens, W C, Eisenhauer, E A, Jolivet, J, Ernst, S, Moore, M, Muldal, A

“…Most patients diagnosed with renal carcinoma developed metastatic disease at some time during their course, with available therapy inducing response in only a…”
Get more information

Effect of indomethacin plus ranitidine in advanced melanoma patients on high-dose interleukin-2 by Mertens, W C, Bramwell, V H, Gwadry-Sridhar, F, Romano, W, Banerjee, D, Lala, P K

“…Preclinical models of advanced melanoma have shown that chronic indomethacin therapy combined with interleukin 2 (IL-2) can eradicate experimental metastases…”
Get more information

Strontium 89 therapy and relief of pain in patients with prostatic carcinoma metastatic to bone: a dose response relationship? by Mertens, W C, Stitt, L, Porter, A T

“…Reports published in the English literature of clinical trials utilizing intravenous strontium 89 (89Sr) in the treatment of patients with prostatic…”
Get more information

Glutathione S-transferase expression in renal cell carcinoma: a new marker of differentiation by Grignon, D J, Abdel-Malak, M, Mertens, W C, Sakr, W A, Shepherd, R R

“…Expression of two GST isoenzymes (alpha and pi) was assessed immunohistochemically in 46 cases of renal cell carcinoma (RCC) for which clinical follow-up was…”
Get more information

Oral indomethacin and ranitidine in advanced melanoma: A phase II study by Mertens, W.C., Lohmann, R.C.

“…As a result of preclinical data demonstrating the antitumour and antimetastatic efficiency of indomethacin in murine models, and the clinical observation of…”
Get full text

Adenocarcinoma of the eccrine sweat gland: Response to both combination chemotherapy and local field irradiation by Mertens, W.C., Shum, D.T., Gilchrist, J.A.

Get full text

Adjuvant chemotherapy in the treatment of soft-tissue sarcoma by Mertens, W C, Bramwell, V H

“…Standard therapy for treatment of soft-tissue sarcoma dictates adequate surgical resection with or without radiation therapy. However, metastases occur in a…”
Get more information

Adjuvant chemotherapy for soft tissue sarcomas by Mertens, W C, Bramwell, V H

“…Despite considerable interest in this subject and the completion of a number of randomized trials, the use of adjuvant chemotherapy after definitive local…”
Get more information

Strontium-89 and Low-Dose Infusion Cisplatin for Patients with Hormone Refractory Prostate Carcinoma Metastatic to Bone: A Preliminary Report by Mertens, Wilson C, Porter, Arthur T, Reid, Robert H, Powe, John E

“…Strontium-89 has been used for the treatment of painful bony metastases in patients suffering from disseminated adenocarcinoma of the prostate, with a variable…”
Get full text

Malignant paraganglioma with skeletal metastases and spinal cord compression: response and palliation with chemotherapy by Mertens, W C, Grignon, D J, Romano, W

“…Paragangliomas (carotid body tumours, chemodectomas) may arise in any area of the body where sympathetic ganglia are present, including chemoreceptors, the…”
Get more information

Differential aspects of sleep epilepsy by Young, G B, Blume, W T, Wells, G A, Mertens, W C, Eder, S

“…A review of patients with epilepsy showed that 5.9% had seizures exclusively in sleep (ES) and 4.7% had seizures predominantly but not exclusively in sleep…”
Get more information

Osteosarcoma and other tumors of bone by Mertens, Wilson C, Bramwell, Vivien

“…Steady progress has been made in the identification of genetic alterations and prognostic factors in osteosarcoma. Imaging studies continue to be employed not…”
Get full text

Osteosarcoma and other tumors of bone by Mertens, Wilson C, Bramwell, Vivien

“…Although no major advances in local or systemic therapy have been reported, further progress has been made in the identification of genetic alterations and…”
Get full text

Recalling breast cancer presentation and therapy: Associations between patient inaccuracy and demographic characteristics by Mertens, W. C., Loke, C., Katz, D., Barham, R., Makari-Judson, G.

“…Abstract only…”
Get full text

Breast cancer survivor perceptions regarding relapse and related disease risk by Makari-Judson, G., Loke, C., Katz, D., Barham, R., Mertens, W. C.

“…Abstract only…”
Get full text

Sustained oral indomethacin and ranitidine with intermittent continuous infusion interleukin-2 in advanced renal cell carcinoma by Mertens, W C, Bramwell, V H, Banerjee, D, Gwadry-Sridhar, F, al-Mutter, N, Parhar, R S, Lala, P K

“…Experimental work in murine models has shown that, during the development of tumors, prostaglandin E2 produced by host macrophages inactivates natural killer…”
Get more information